Our laboratory is "Bio Mass Analysis Laboratory”. We are conducting biomarker discovery using OMIX technology and studying the development of new drug action point. We are also studying the validity of biomarker candidates using statistical and molecular biological tools. Until now, we have been studying biomarkers of cardiovascular disease, rheumatoid arthritis, gastric cancer and colorectal cancer related diseases, and will continue to study the usefulness of biomarker candidates, tissue specificity and mechanism of the action. On the other hand, we are developing new analysis methods and diagnostic kits. The development of diagnostic kits with high sensitivity and specificity by collaborating with other researchers working on new materials are going on. Capillary Electrophoresis-laser induced fluorescence, MALDI-TOF MS and Nano or Micro LC-MS/ MS equipment are employed for new analytical and diagnostic method development.